Cystinosis Results Help Rebuild Confidence In AvroBio’s Gene Therapy
Potential Registrational Study To Start This Year
The lentiviral gene therapy company is still trading below cash, but the cystinosis results add extra momentum to its comeback.
The lentiviral gene therapy company is still trading below cash, but the cystinosis results add extra momentum to its comeback.